Endogenous prostaglandin E-2 and insulin-like growth factor 1 can modulatethe levels of parathyroid hormone receptor in human osteoarthritic osteoblasts
G. Hilal et al., Endogenous prostaglandin E-2 and insulin-like growth factor 1 can modulatethe levels of parathyroid hormone receptor in human osteoarthritic osteoblasts, J BONE MIN, 16(4), 2001, pp. 713-721
Subchondral bone sclerosis may be important for the onset and/or progressio
n of cartilage loss/damage in human osteoarthritis (OA). OA osteoblasts are
resistant to parathyroid hormone (PTH) stimulation, which could explain bo
ne sclerosis via the inhibition of PTH-dependent catabolism. Here, we inves
tigated the molecular mechanism(s) responsible for reduced PTH-dependent cy
clic adenosine monophosphate (cAMP) synthesis in OA subchondral osteoblasts
. Although cholera toxin (CTX) increased basal cAMP formation in these cell
s, it failed to stimulate PTH-dependent cAMP synthesis, whereas pertussis t
oxin (PTX) did not inhibit basal cAMP, yet diminished PTH-dependent cAMP pr
oduction. Binding of I-125-PTH indicated lower PTH receptor levels in OA th
an in normal osteoblasts (-50.5 +/- 9.5%). This could be attributed to eith
er reduced expression of the PTH receptor (PTH-R) or altered recycling of e
xisting pools of receptors. Reverse-transcription polymerase chain reaction
(RT-PCR) analysis indicated decreased PTH-R messenger RNA (mRNA) levels in
OA cells that were highly variable (ranging from -10% to -60%), a situatio
n that reflects disease severity. Interestingly, OA osteoblasts produced mo
re prostaglandin E-2 (PGE(2)) than normal osteoblasts, and using naproxen,
a cyclo-oxygenase inhibitor, increased PTH-dependent cAMP formation to a le
vel similar to normal osteoblasts. Because heterologous desensitization can
explain a decrease in PTH binding but cannot account for reduced PTH-R exp
ression, we looked at the possible effect of insulin-like growth factor 1 (
IGF-1) on this parameter. Blocking IGF-1 signaling with a neutralizing rece
ptor antibody increased I-125-PTH binding in both normal and OA osteoblasts
. Conversely, treatments with IGF-1 receptor (IGF-1R) antibody only slightl
y increased the levels of PTH-R mRNA whereas the addition of IGF-1 signific
antly reduced PTH-R mRNA levels (-24.1 +/- 7.1%), yet neither PGE, nor napr
oxen modified PTH-R levels. These results suggest that both IGF-1 signaling
and PGE, formation repress PTH-dependent response in OA osteoblasts, a sit
uation that can contribute to abnormal bone remodeling and bone sclerosis i
n OA.